Evidence map›Paper›PMID 34269882›Full record

ArticleJournal of cancer research and clinical oncology2021

Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.

Wanting Shao, Christina Kuhn, Doris Mayr, Nina Ditsch, Magdalena Kailuwait, Verena Wolf, Nadia Harbeck, Sven Mahner, Udo Jeschke, Vincent Cavaillès and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research and clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Wanting ShaoDepartment of Obstetrics and Gynecology, Breast Center, LMU University Hospital, Munich, Germany.
Christina KuhnDepartment of Gynecology and Obstetrics, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.
Doris MayrDepartment of Pathology, LMU Munich, Munich, Germany.
Nina DitschDepartment of Gynecology and Obstetrics, University Hospital Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.
Magdalena KailuwaitDepartment of Obstetrics and Gynecology, Breast Center, LMU University Hospital, Munich, Germany.
Verena WolfDepartment of Obstetrics and Gynecology, Breast Center, LMU University Hospital, Munich, Germany.
Nadia HarbeckDepartment of Obstetrics and Gynecology, Breast Center, LMU University Hospital, Munich, Germany.
Sven MahnerDepartment of Obstetrics and Gynecology, Breast Center, LMU University Hospital, Munich, Germany.
Udo JeschkeDepartment of Obstetrics and Gynecology, Breast Center, LMU University Hospital, Munich, Germany. udo.jeschke@med.uni-muenchen.de.ORCID http://orcid.org/0000-0003-2623-3235
Vincent CavaillèsIRCM-Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université Montpellier, Parc Euromédecine, 208 rue des Apothicaires, F-34298, Montpellier, France.
Sophie SixouDepartment of Obstetrics and Gynecology, Breast Center, LMU University Hospital, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34269882
PMCPMC8587370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.